MedTrace Logo

Azilsartan Tablets Special Drug Use Surveillance: Long-term Use

NCT02092025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3437

Last updated 2019-01-15

Study results available
· View outcomes & findings →

Summary

The purpose of this survey is to evaluate the safety and efficacy of long-term use of azilsartan tablets (Azilva Tablets) in patients with hypertension in a routine clinical setting.

Conditions

Interventions

DRUG

Azilsartan

Azilsartan tablets

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-20
Primary Completion
2016-01-15
Completion
2016-01-15

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02092025 on ClinicalTrials.gov